Pharmacovigilance Ukraine

street Kostelna 3 of. 7

Kiev, 01001, Ukraine

Tel.:  + 38 044 228 37 89 

Fax: + 38 044 278 08 07

e-mail: info@mbiotech.com.ua

For M.Biotech Limited company a major concern is to provide the consumers with high-quality, effective and safe drugs where the benefits of use exceed the possible risks. In order to monitor the safety and efficacy of our medicines we have established the Pharmacovigilance Department.

When adverse events occur, our specialists investigate the causes and make their efforts to minimize and prevent the adverse events in the future.

We would be grateful for any information regarding non-typical manifestations, side-effects or lack of efficacy while using our medicinal products.

The information you submit is strictly confidential and will not be disclosed, except for the cases stipulated by the law.

Do you want to reduce the risk of an adverse reaction?

Carefully and attentively keep your medical documentation, where you should keep all information about your health grounds, diagnostic findings and lab results, consultations of medical specialists, possible intolerance to several medications. Attentively read leaflet for medical use and adhere to the medication regimen.

Tell your doctor if:

  • You have intercurrent diseases;

  • You are constantly taking any medications;

  • In the past there were cases of allergic reactions;

  • Earlier, you had adverse reactions to any medications.

Ask your doctor:

  • How to monitor the intake of drug?

  • When is it necessary to visit a doctor to monitor the health grounds?

  • When and where can the drug be cancelled?

  • What are the first signs of known side effects?

PLEASE, AVOID SELF-TREATMENT!

Be attentive to your health and if you have the first signs of worsening health grounds, consult a doctor. The risk of side effects includes:

  • People of elderly and senile age;

  • Patients who receive long-term courses of treatment;

  • Pregnant women and premature babies;

  • Patients with severe systemic diseases, such as kidney, liver, blood, immune system or other diseases;

  • Patients taking more than 4 drugs simultaneously or receiving treatment for several diseases simultaneously.